Main Menu (Mobile)- Block

Main Menu - Block

R3 - Replace, Repair, Regenerate

janelia7_blocks-janelia7_secondary_menu | block
More in this Conferences
node_title | node_title

R3 - Replace, Repair, Regenerate

custom_misc-custom_misc_format_date | block
July 21 - 22, 2021
node:field_image | entity_field
node:field_content_summary | entity_field

Organized by Kara McKinley (Harvard), Shruti Naik (NYU) and Mike Longaker (Stanford), this is the sixth in a series of planning workshops that will serve an important role in shaping a 15-lab, 15-year research program at Janelia Research Campus called “4D Cellular Physiology”.

node_body | node_body

This workshop will focus on clinical and mechanistic paradigms in tissue repair. The capacity to restore cells and structures after injury differs dramatically across tissues and between species. Why can some tissues and organisms recreate structures virtually identical to what was lost, while others fail to repair at all, or seal the damage but remain functionally impaired? Our goal is to define key chokepoints, and forge new frontiers to ultimately advance regenerative medicine in humans. By bringing together biologists, clinicians, and bioengineers working in diverse systems, we aim to foster the cross-pollination of ideas across disciplines.

The virtual format will include ~5 hours of short talks and discussion each day, open to the broad scientific community. Presentations by invited speakers will focus on current challenges in the field and exciting new directions that could lead to transformative advances.

This workshop will serve an important role in shaping Janelia’s ongoing research program, providing critical background for a new approach to collaboratively tackle some of the most important problems in modern biomedical research. 

Graduate students, postdocs and other trainees are invited to submit an abstract for consideration for a short talk on your work.

Applications are closed for this workshop.



Mike Longaker, Stanford University 
Kara McKinley, Harvard University
Shruti Naik, New York University


Aileen Anderson, University of California Irvine
Sumru Bayin, Memorial Sloan Kettering Cancer Center
Charles Chan, Stanford University
Agnieszka Czechowicz, Stanford University
Mark Davis, HHMI/Stanford University
Stuart Forbes, University of Edinburgh
Amy Gleichman, University of California - Los Angeles
Allison Goldstein, National Institute of Health
Anjelica Gonzalez, Yale University
Farshid Guilak, Washington University in St. Louis
Kevin Healy, University of California, Berkeley
Boris Hinz, University of Toronto
Yuemeng Jia, The University of Texas Southwestern Medical Center
Carla Kim, Harvard Medical School
Paul Kubes, University of Calgary
Wouter Masselink, Research Institute of Molecular Pathology
Ruslan Medzhitov, HHMI/Yale University
Samira Musah, Duke University
Ahmad Nabhan, Genentech
Laura Niklason, Yale University
Ysbrand Nusse, University of Calgary
Eric Olson, University of Texas Southwestern
Kenneth Poss, Duke University
Pamela Robey, National Institute of Dental and Craniofacial Research/NIH
Alejandro Sánchez Alvarado, HHMI/Stowers Institute for Medical Research
Robert Saxton, Stanford University
Thaddeus Stappenbeck, Cleveland Clinic Lerner Research Institute
Lorenz Studer, Memorial Sloan Kettering Cancer Center
Elly Tanaka, Research Institute of Molecular Pathology (IMP)
Anastasia Tikhonova, University of Toronto
Thomas Wynn, Pfizer Inc.
Yifan Yuan, Yale University

Discussion Leaders

Semir Beyaz, Cold Spring Harbor Laboratory
Dennis Discher, University of Pennsylvania
Ruth Franklin, Harvard Medical School
Yaron Fuchs, Technion
Valerie Horsley, Yale University
Kristin Knouse, Koch Institute/MIT
Jason Mills, Baylor College of Medicine
Nipam Patel, Marine Biological Laboratory (MBL)
Thomas Rando, Stanford University
Quinton Smith, University of California, Irvine
Mansi Srivastava, Harvard University
Molly Stevens, Imperial College London
Amy Wagers, Harvard University